Annemieke Geluk Selected Research

Tuberculoid Leprosy

1/2018	BCG and Adverse Events in the Context of Leprosy.
12/2012	Mycobacterium leprae virulence-associated peptides are indicators of exposure to M. leprae in Brazil, Ethiopia and Nepal.
12/2012	Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annemieke Geluk Research Topics

Disease

56	Leprosy (Hansen's Disease) 12/2021 - 09/2005
31	Infections 12/2021 - 01/2002
26	Tuberculosis (Tuberculoses) 12/2021 - 05/2002
7	Paucibacillary Leprosy 01/2021 - 09/2005
5	Inflammation (Inflammations) 11/2020 - 02/2014
3	Tuberculoid Leprosy 01/2018 - 12/2012
2	Rheumatoid Arthritis 11/2020 - 08/2017
2	Lung Diseases (Lung Disease) 01/2020 - 01/2018
2	Disease Progression 08/2017 - 12/2012
2	Chronic Disease (Chronic Diseases) 08/2017 - 12/2011
2	HIV Infections (HIV Infection) 01/2016 - 02/2010
2	Coinfection 06/2014 - 05/2013
2	Virus Diseases (Viral Diseases) 01/2013 - 09/2005
2	Multibacillary Leprosy 12/2012 - 09/2005
1	Pulmonary Tuberculosis 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 08/2017
1	Communicable Diseases (Infectious Diseases) 10/2015
1	Latent Infection 09/2015
1	Uveitis 04/2014
1	Erythema Nodosum 01/2014
1	Neoplasms (Cancer) 01/2013
1	Congenital Abnormalities (Deformity) 12/2011
1	Hypoxia (Hypoxemia) 07/2007
1	Uterine Cervical Dysplasia 01/2002

Drug/Important Bio-Agent (IBA)

26	AntigensIBA 12/2021 - 01/2002
24	Biomarkers (Surrogate Marker)IBA 12/2021 - 05/2012
19	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2002
12	VaccinesIBA 06/2021 - 07/2007
10	Peptides (Polypeptides)IBA 09/2015 - 12/2005
9	AntibodiesIBA 01/2021 - 03/2008
6	GlycolipidsIBA 12/2021 - 03/2008
5	Immunoglobulin M (IgM)IBA 11/2021 - 12/2018
5	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 10/2013
5	Interferon-gamma (Interferon, gamma)IBA 08/2017 - 12/2002
4	CytokinesIBA 11/2020 - 03/2009
4	Recombinant ProteinsIBA 02/2011 - 09/2005
3	Complement System Proteins (Complement)IBA 01/2020 - 07/2007
3	BCG Vaccine FDA Link 03/2015 - 07/2007
3	EpitopesIBA 01/2014 - 09/2005
3	Tuberculin (PPD)IBA 01/2014 - 06/2007
2	Interleukin-6 (Interleukin 6)IBA 12/2021 - 01/2012
2	Mycobacterium tuberculosis antigensIBA 06/2021 - 01/2020
2	RNA (Ribonucleic Acid)IBA 06/2021 - 11/2019
2	Blood Proteins (Serum Proteins)IBA 01/2021 - 01/2016
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2017
2	ChemokinesIBA 11/2020 - 01/2014
2	S100A12 ProteinIBA 01/2020 - 09/2019
2	InterferonsIBA 10/2019 - 12/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2004
2	Pharmaceutical PreparationsIBA 06/2014 - 12/2012
2	HLA-DR Antigens (HLA-DR)IBA 06/2014 - 04/2014
2	HLA-DR3 Antigen (HLA DR3 Antigen)IBA 12/2012 - 09/2005
2	Indicators and Reagents (Reagents)IBA 12/2012 - 12/2005
2	HLA Antigens (Human Leukocyte Antigens)IBA 06/2006 - 09/2005
1	TrisaccharidesIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 11/2020
1	ElementsIBA 01/2020
1	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2020
1	N 30IBA 01/2020
1	A-Form DNA (A-DNA)IBA 12/2019
1	Interleukin-15 (Interleukin 15)IBA 11/2019
1	Interleukin-10 (Interleukin 10)IBA 09/2019
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2019
1	Biological ProductsIBA 08/2017
1	Antirheumatic Agents (DMARD)IBA 08/2017
1	amsonic acid (DAS)IBA 08/2017
1	GoldIBA 01/2017
1	Complement Factor H (Factor H)IBA 01/2016
1	Prealbumin (Transthyretin)IBA 01/2016
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2016
1	C-Reactive ProteinIBA 01/2016
1	Messenger RNA (mRNA)IBA 01/2014
1	Protein Sorting Signals (Signal Peptide)IBA 01/2013
1	ProteomeIBA 12/2012
1	Immunodominant EpitopesIBA 12/2012
1	BuffersIBA 10/2011
1	Mycobacterium leprae phenolic glycolipid IIBA 02/2011
1	AcidsIBA 02/2011
1	lipoarabinomannan (LAM)IBA 02/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2007
1	ChitosanIBA 04/2004
1	DNA VaccinesIBA 04/2004
1	Staphylococcal Protein A (Protein A)IBA 01/2002

Therapy/Procedure

7	Therapeutics 12/2021 - 03/2008
2	Aftercare (After-Treatment) 11/2019 - 04/2016
2	Drug Therapy (Chemotherapy) 10/2013 - 12/2011
1	Resuscitation 01/2014
1	Chemoprevention 10/2013